Sotac Pharmaceuticals Limited

₹130.00As of Sun 8 Nov 2026, 12:00 UTC
NSE:SOTACHealthcare
Country India
PE (Fwd) •••
TSR 4Y CAGR 3.61%
Div yield 0.15%
ROE 10.23%
Medical (Pharmaceuticals)
Beta (5Y) (0.18)
PE TTM 24.91
TSR TTM 0.34%
Mkt cap ₹1.437B
ROIC 9.05%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹146
12.38%
434.34%
Hold 10|10|2|10|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
3.02
2.89
3.16
3.07
16.49%
5.46%
8.59%
(2.99%)
Revenue₹M
97.41
96.34
100.7
98.22
13.95%
7.41%
8.71%
6.02%
Peers (US$15.30M)
Cap (US$)
PE
14.80M
9.350x
8.858M
43.29x
7.067M
16.83x
19.24M
54.62x
Capital
TTM
5Y
10Y
Leveragex
0.065
(1.418)
(1.313)
EBIT/Intx
0.159
0.550
0.523
Own earn%
(68.68)
60.54
75.98
Sh yield%
39.49
43.74
40.39
Owners
Insiders/Inst%
10.58
57.41
Short interest%
0.66
SBC / revenue%
2.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–7
$1 testx
—
Incr. ROIC%
6